Cyteir Therapeutics, Inc.

CYT · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$46-$42-$21-$15
Dep. & Amort.$1$0$0$0
Deferred Tax$0-$4-$0$0
Stock-Based Comp.$5$3$0$0
Change in WC-$3$2$1-$2
Other Non-Cash$1$4$0-$1
Operating Cash Flow-$43-$36-$19-$18
Investing Activities
PP&E Inv.-$0-$1-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$1-$1-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$1$37
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$216$1$37
Financing Cash Flow$0$0$1$37
Forex Effect$0$0$0$0
Net Chg. in Cash-$43$179-$18$19
Supplemental Information
Beg. Cash$190$11$29$10
End Cash$147$190$11$29
Free Cash Flow-$43-$37-$19-$18
Cyteir Therapeutics, Inc. (CYT) Financial Statements & Key Stats | AlphaPilot